A share price of Tyra Biosciences Inc [TYRA] is currently trading at $16.04, up 0.88%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TYRA shares have gain 6.01% over the last week, with a monthly amount glided 6.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tyra Biosciences Inc [NASDAQ: TYRA] stock has seen the most recent analyst activity on September 03, 2025, when Raymond James initiated its Strong Buy rating and assigned the stock a price target of $35. On January 07, 2025, UBS initiated with a Buy rating and assigned a price target of $28 on the stock. BofA Securities upgraded its rating to a Buy and increased its price target to $31 on October 18, 2024. Piper Sandler initiated its recommendation with an Overweight and recommended $33 as its price target on August 15, 2024. BofA Securities downgraded its rating to Neutral for this stock on December 15, 2023, and downed its price target to $15. In a note dated June 30, 2023, Wedbush initiated an Outperform rating and provided a target price of $27 on this stock.
Tyra Biosciences Inc experienced fluctuations in its stock price throughout the past year between $6.42 and $17.27. Currently, Wall Street analysts expect the stock to reach $36 within the next 12 months. Tyra Biosciences Inc [NASDAQ: TYRA] shares were valued at $16.04 at the most recent close of the market. An investor can expect a potential return of 124.44% based on the average TYRA price forecast.
Analyzing the TYRA fundamentals
Gross Profit Margin for this corporation currently stands at -0.33% with Operating Profit Margin at -245.26%, Pretax Profit Margin comes in at -213.37%, and Net Profit Margin reading is -213.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.32 and Total Capital is -0.4. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.17 points at the first support level, and at 14.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.58, and for the 2nd resistance point, it is at 17.12.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Tyra Biosciences Inc [NASDAQ:TYRA] is 17.71. Further, the Quick Ratio stands at 17.71, while the Cash Ratio is 7.15.
Transactions by insiders
Recent insider trading involved Daniel Bensen, Officer, that happened on Nov 18 ’25 when 0.12 million shares were purchased. Chief Operating Officer, Bensen Daniel completed a deal on Nov 14 ’25 to sell 0.11 million shares. Meanwhile, Chief Operating Officer Bensen Daniel sold 20072.0 shares on Nov 17 ’25.
